159 related articles for article (PubMed ID: 32209402)
41. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
42. Apolipoprotein E genotype and Alzheimer's disease.
Noguchi S; Murakami K; Yamada N
Lancet; 1993 Sep; 342(8873):737. PubMed ID: 8103832
[No Abstract] [Full Text] [Related]
43. APOE loss of function: A genetic shield against Alzheimer's disease.
Tate MD; Karahan H; Kim J
Neuron; 2024 Apr; 112(7):1033-1035. PubMed ID: 38574724
[TBL] [Abstract][Full Text] [Related]
44. No association between apolipoprotein E genotype and late-onset depression in Alzheimer's disease.
Cantillon M; Harwood D; Barker W; St George-Hyslop P; Tsuda T; Ekatarina R; Duara R
Biol Psychiatry; 1997 Jan; 41(2):246-8. PubMed ID: 9018400
[No Abstract] [Full Text] [Related]
45. The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update.
Mahoney-Sanchez L; Belaidi AA; Bush AI; Ayton S
J Mol Neurosci; 2016 Nov; 60(3):325-335. PubMed ID: 27647307
[TBL] [Abstract][Full Text] [Related]
46. Alzheimer's disease: phenotypes and genotypes.
Sorbi S; Forleo P; Nacmias B
Funct Neurol; 1997; 12(3-4):147-51. PubMed ID: 9218968
[No Abstract] [Full Text] [Related]
47. APOE targeting strategy in Alzheimer's disease: lessons learned from protective variants.
Bu G
Mol Neurodegener; 2022 Aug; 17(1):51. PubMed ID: 35922805
[No Abstract] [Full Text] [Related]
48. Just caring: the moral and economic costs of APOE genotyping for Alzheimer's disease.
Fleck LM
Ann N Y Acad Sci; 1996 Dec; 802():128-38. PubMed ID: 8993492
[No Abstract] [Full Text] [Related]
49. Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.
Lippa CF; Smith TW; Saunders AM; Hulette C; Pulaski-Salo D; Roses AD
Neurology; 1997 Feb; 48(2):515-9. PubMed ID: 9040748
[TBL] [Abstract][Full Text] [Related]
50. Hippocampal apolipoprotein D level depends on Braak stage and APOE genotype.
Glöckner F; Ohm TG
Neuroscience; 2003; 122(1):103-10. PubMed ID: 14596852
[TBL] [Abstract][Full Text] [Related]
51. Clinical Application of APOE in Alzheimer's Prevention: A Precision Medicine Approach.
Berkowitz CL; Mosconi L; Rahman A; Scheyer O; Hristov H; Isaacson RS
J Prev Alzheimers Dis; 2018; 5(4):245-252. PubMed ID: 30298183
[TBL] [Abstract][Full Text] [Related]
52. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
Anwar N; Lovestone S; Cheetham ME; Levy R; Powell JF
Lancet; 1993 Nov; 342(8882):1308-9. PubMed ID: 7901622
[No Abstract] [Full Text] [Related]
53. Prevalence of Alzheimer's disease and apolipoprotein E allele frequencies in the Old Order Amish.
Holder J; Warren AC
J Neuropsychiatry Clin Neurosci; 1998; 10(1):100-2. PubMed ID: 9547474
[TBL] [Abstract][Full Text] [Related]
54. Apolipoprotein E Genotyping in Alzheimer's Disease. Chicago, Illinois, October 21-22, 1995. Proceedings.
Ann N Y Acad Sci; 1996 Dec; 802():1-224. PubMed ID: 9012314
[No Abstract] [Full Text] [Related]
55. Apolipoprotein E genotype and Alzheimer's disease.
Payami H; Kaye J; Heston LL; Bird TD; Schellenberg GD
Lancet; 1993 Sep; 342(8873):738. PubMed ID: 8103834
[No Abstract] [Full Text] [Related]
56. ApoE-epsilon 4 and early-onset Alzheimer's.
Okuizumi K; Onodera O; Tanaka H; Kobayashi H; Tsuji S; Takahashi H; Oyanagi K; Seki K; Tanaka M; Naruse S
Nat Genet; 1994 May; 7(1):10-1. PubMed ID: 8075630
[No Abstract] [Full Text] [Related]
57. No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease.
Didierjean O; Martinez M; Campion D; Hannequin D; Dubois B; Martin C; Puel M; Thomas Anterion C; Pasquier F; Moreau O; Babron MC; Penet C; Agid Y; Clerget-Darpoux F; Frebourg T; Brice A
J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):103-5. PubMed ID: 9221977
[TBL] [Abstract][Full Text] [Related]
58. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.
Drzezga A; Grimmer T; Henriksen G; Mühlau M; Perneczky R; Miederer I; Praus C; Sorg C; Wohlschläger A; Riemenschneider M; Wester HJ; Foerstl H; Schwaiger M; Kurz A
Neurology; 2009 Apr; 72(17):1487-94. PubMed ID: 19339712
[TBL] [Abstract][Full Text] [Related]
59. Tipping the scales towards routine APOE genotyping.
Dunne R; Coulthard E
J Neurol Neurosurg Psychiatry; 2023 Sep; 94(9):669. PubMed ID: 37414535
[No Abstract] [Full Text] [Related]
60. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
Czech C; Mönning V; Tienari PJ; Hartmann T; Masters C; Beyreuther K; Förstl H
Lancet; 1993 Nov; 342(8882):1309. PubMed ID: 7901624
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
